InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
17
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Robins Chad M, Chief Executive Officer. Insider active across 1 company, notably Adaptive Biotechnologies Corp. Cumulatively, 29 disclosures have been published. Split: 0 buy · 17 sells. Total volume traded: €28.1m. History available since 15 June 2021. The latest transaction was filed on 17 August 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Robins Chad M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations29 total
321,324 shares@ US$6.55Common StockSEC:0001780649-26-000014:0
318,799 shares@ US$25.08Common StockSEC:0001780649-26-000014:1
2,525 shares@ US$25.57Common StockSEC:0001780649-26-000014:2
278,676 shares@ US$6.55Common StockSEC:0001780649-26-000014:3
278,472 shares@ US$24.48Common StockSEC:0001780649-26-000014:4
204 shares@ US$25.14Common StockSEC:0001780649-26-000014:5
83,332 shares@ US$14.410.051% mcap5.9% of flowCommon StockSEC:0001780649-26-000011:0
140,567 shares@ US$13.178.2% of flowCommon StockSEC:0001780649-26-000007:0
127,813 shares0Common StockSEC:0001780649-26-000005:0
182,891 shares@ US$15.990.12% mcap14.1% of flowCommon StockSEC:0001780649-26-000003:0
124,998 shares@ US$18.440.095% mcap11.0% of flowCommon StockSEC:0001780649-26-000002:0
124,998 shares@ US$15.590.081% mcap9.4% of flowCommon StockSEC:0001780649-26-000001:0
35,736 shares@ US$19.680.030% mcap3.5% of flowCommon StockSEC:0001780649-25-000003:0
86,161 shares@ US$14.736.2% of flowCommon StockSEC:0001780649-25-000002:0
355,000 shares0Common StockSEC:0001062993-25-004809:0
186,080 shares@ US$6.324.4% of flowCommon StockSEC:0001062993-25-003241:0
158,921 shares@ US$6.323.8% of flowCommon StockSEC:0001062993-25-002744:2
158,921 shares@ US$8.465.1% of flowCommon StockSEC:0001062993-25-002744:3
100,287 shares@ US$6.322.4% of flowCommon StockSEC:0001062993-25-002744:0
100,287 shares@ US$8.443.2% of flowCommon StockSEC:0001062993-25-002744:1
211,160 shares@ US$6.325.0% of flowCommon StockSEC:0001062993-25-002744:4
211,160 shares@ US$8.506.7% of flowCommon StockSEC:0001062993-25-002744:5
354,610 shares0Common StockSEC:0001062993-24-005758:0
354,610 shares0Common StockSEC:0001062993-23-006321:0
14,815 shares@ US$6.320.4% of flowCommon StockSEC:0001209191-22-017696:0
25 of 29 declarations
About Robins Chad M
ROBINS CHAD M is Directeur Général and, at Adaptive Biotechnologies Corp (XNAS), is listed as CEO and Chairman. The record shows 23 filings in total, and across the sampled recent filings, all transactions are sales, for EUR 15272858 between 2021-06-17 and 2026-04-08.
